Scientists in bowel cancer breakthrough
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists have established how bowel cancer turns aggressive, leading the way for potential new drug treatments, it has been revealed.
Researchers in Cardiff and Glasgow are behind a study which showed how a particular protein stimulates tumours, making them more likely to spread.
The protein called AKT is triggered when another, called Pten, is faulty and coincides with a third protein known as APC.
The authors of the research identified AKT as a strong lead for drug development to treat bowel cancer.
Professor Alan Clarke, a Cancer Research UK scientist at the Cardiff School of Biosciences, said: "We now have a model of how bowel cancer progresses.
"This has given us a clearer picture of how bowel tumours actually grow and provides scientists with crucial information for drug design to slow down or stop the spread of the disease.
"We now know that the protein kinase AKT is a real lead for drug development to target aggressive intestinal cancer, which is something we didn't properly appreciate before."
Cancer is caused by uncontrolled cell growth and division.
Cancer Research UK, whose team at the Beatson Institute in Glasgow also worked on the study, said that identifying key proteins which control molecular networks inside cells and establishing what happens when these proteins become faulty was "fundamental" to our understanding of how the disease develops.
Dr Lesley Walker, the charity's director of cancer information, said: "Bowel cancer is one of the most common diseases in the UK and it is much more difficult to treat when it is advanced, so we welcome any research that gives us opportunities for better treatment."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments